相关实验视频
Updated: Jan 7, 2026

03:37
Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
5.0K
注射药物用于体重管理.
Natasha Yates1,2,3, Terri-Lynne South1,2,3
1New Medical Education Australia, Brisbane.
Australian prescriber
|December 19, 2025
概括
可以注射的体重控制药物,如GLP-1激动剂,通过模仿激素来减少食欲来帮助治疗肥胖. 长期使用通常是必要的,具有潜在的风险,包括胃肠道问题和胰腺炎,需要仔细监测患者.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 代谢性疾病研究研究.
背景情况:
- 肥胖管理需要一个多方面的方法,整合行为变化和专业监测.
- 注射药物越来越多地用于体重控制.
- 关键药物类别包括葡萄糖类-1 (GLP-1) 受体激动剂和双GIP/GLP-1受体激动剂.
研究的目的:
- 审查当前注射式减肥药物的作用机制.
- 讨论与这些疗法相关的疗效和潜在不良影响.
- 强调长期遵守和患者监测的重要性.
主要方法:
- 对用于体重管理的GLP-1受体激活剂和GIP/GLP-1受体激活剂的当前文献的综述.
- 对药物机制的分析,包括食欲调节和代谢作用.
- 检查报告的不良事件和临床考虑.
主要成果:
- 这些可注射药物模仿内激素 (GLP-1,GIP) 降低食欲,改变食物感知,减缓胃排空,增强胰岛素分泌.
- 停止服用后体重恢复很常见,这表明需要持续治疗.
- 常见的副作用是胃肠道;更罕见但严重的风险包括胆结石和胰腺炎.
结论:
- 可注射的基因基因模仿剂在与生活方式干预相结合时,在肥胖管理中提供了重要的工具.
- 通常需要长期治疗,因此需要持续监测患者的疗效和安全性.
- 仔细考虑潜在的不良影响和患者选择至关重要,包括监测心理健康影响和滥用.
相关概念视频
Insulin Formulations: Types and Delivery
597
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
597
Glucagon-like Receptor Agonists
809
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
809
Insulin: Dosing Regimen and Adverse Effects
644
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
644
Drug Delivery: Miscellaneous Routes
690
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
690
Drug Dosing: Obese Patients
189
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
189
Drug Delivery: Parenteral Route
1.4K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.4K

